These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28844295)

  • 21. Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients.
    Cirimele V; Kintz P; Gosselin O; Ludes B
    Forensic Sci Int; 2000 Jan; 107(1-3):289-300. PubMed ID: 10689581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics.
    Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K
    Int J Neuropsychopharmacol; 2017 Jul; 20(7):529-537. PubMed ID: 28340122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating depression in schizophrenia.
    Lund BC; Perry PJ; Miller DD
    Am J Psychiatry; 2001 Sep; 158(9):1528-9. PubMed ID: 11532750
    [No Abstract]   [Full Text] [Related]  

  • 24. Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients.
    Wong JO; Leung SP; Mak T; Ng RM; Chan KT; Hon-Kee Cheung H; Choi WK; Lai J; Wai-Kiu Tsang A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):251-64. PubMed ID: 16316716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
    Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
    Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.
    Diaz FJ; Santoro V; Spina E; Cogollo M; Rivera TE; Botts S; de Leon J
    Pharmacopsychiatry; 2008 May; 41(3):81-91. PubMed ID: 18484549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder.
    Hanssens L; van Winkel R; Wampers M; Van Eyck D; Scheen A; Reginster JY; Collette J; Peuskens J; De Hert M
    Schizophr Res; 2008 Dec; 106(2-3):308-14. PubMed ID: 18930377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia.
    Schulte P
    Clin Pharmacokinet; 2003; 42(7):607-18. PubMed ID: 12844323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia.
    Guitton C; Kinowski JM; Abbar M; Chabrand P; Bressolle F
    J Clin Pharmacol; 1999 Jul; 39(7):721-8. PubMed ID: 10392327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
    Freudenreich O; Weiner RD; McEvoy JP
    Biol Psychiatry; 1997 Jul; 42(2):132-7. PubMed ID: 9209730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine.
    Caniato RN; Alvarenga ME; Garcia-Alcaraz MA
    Aust N Z J Psychiatry; 2006 Aug; 40(8):691-7. PubMed ID: 16866765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Srivastava A; Jacob M; Jacob KS
    Psychopharmacology (Berl); 2012 Dec; 224(3):441-9. PubMed ID: 22700043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data.
    Ulrich S; Baumann B; Wolf R; Lehmann D; Peters B; Bogerts B; Meyer FP
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of venlafaxine treatment on clozapine plasma levels in schizophrenic patients.
    Repo-Tiihonen E; Eloranta A; Hallikainen T; Tiihonen J
    Neuropsychobiology; 2005; 51(4):173-6. PubMed ID: 15870506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients.
    Piwowarska J; Radziwoń-Zaleska M; Dmochowska M; Szepietowska E; Matsumoto H; Sygitowicz G; Pilc A; Łukaszkiewicz J
    Pharmacol Rep; 2016 Dec; 68(6):1120-1125. PubMed ID: 27588387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
    Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
    J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
    Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
    Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
    Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
    J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
    Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
    J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unanticipated plasma concentrations in two clozapine-treated patients.
    Alfaro CL; McClure RK; Vertrees JE; Benavides R
    Ann Pharmacother; 2001 Sep; 35(9):1028-31. PubMed ID: 11573850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.